Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

ClinicalTrials.gov ID: NCT03109379

Public ClinicalTrials.gov record NCT03109379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-center, Open-label Study of Trospium Delivered Intravesically by TAR-302-5018 to Subjects With Idiopathic Overactive Bladder (iOAB) and Urinary Incontinence

Study identification

NCT ID
NCT03109379
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Taris Biomedical LLC
Industry
Enrollment
43 participants

Conditions and interventions

Interventions

  • Trospium-Releasing Intravesical System (TAR-302-5018) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 3, 2017
Primary completion
Sep 26, 2019
Completion
Sep 26, 2019
Last update posted
Jan 12, 2020

2017 – 2019

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Urological Associates of Southern Arizona Tucson Arizona 85715
Medical Center for Clinical Research San Diego California 92108
Clinical Research Center of Florida Pompano Beach Florida 33060
DelRicht Clinical Research, LLC New Orleans Louisiana 70115
Bay State Clinical Trials, Inc Watertown Massachusetts 02472
William Beaumont Hospital - Royal Oak Royal Oak Michigan 48073
Michigan Institute of Urology Troy Michigan 48084
New Jersey Urology Voorhees Township New Jersey 08043
Accumed Research Garden City New York 11530-1664
Manhattan Medical Resear New York New York 10016
UWCR - Lyndhurst Gynecologic Associates Winston-Salem North Carolina 27103
Urology of Virginia Virginia Beach Virginia 23462

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03109379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03109379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →